BioAge Labs Revenue and Competitors

Location

#6111

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • BioAge Labs's estimated annual revenue is currently $16.1M per year.(i)
  • BioAge Labs's estimated revenue per employee is $155,000
  • BioAge Labs's total funding is $294M.

Employee Data

  • BioAge Labs has 104 Employees.(i)
  • BioAge Labs grew their employee count by 9% last year.

BioAge Labs's People

NameTitleEmail/Phone
1
Co-Founder, CEOReveal Email/Phone
2
Co-founder, COOReveal Email/Phone
3
CMO and EVP ResearchReveal Email/Phone
4
VP Program ManagementReveal Email/Phone
5
VP, Translational Aging BiologyReveal Email/Phone
6
VP MediaReveal Email/Phone
7
SVP, PeopleReveal Email/Phone
8
VP, FinanceReveal Email/Phone
9
VP, CMCReveal Email/Phone
10
SVP Regulatory Affairs & QAReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is BioAge Labs?

BioAge is a clinical-stage biotechnology company that develops drugs to treat aging and aging-related diseases. We've built a systems biology platform to map out the key molecular pathways that impact healthy human aging, based on proprietary human aging cohorts that have blood samples collected up to 45 years ago with participant -omics data that is tied to detailed medical follow-up records over their lifespan. To date, BioAge has raised $127M from Andreessen Horowitz, Kaiser Foundation Hospitals, and others. Recently, BioAge in-licensed our first two platform assets, and for both programs we'll be initiating Phase 2 efficacy trials by H1 2021. Our mission is to develop a pipeline of therapeutic assets that increase healthspan and lifespan. For additional information about BioAge, visit the company's website at www.bioagelabs.com

keywords:N/A

$294M

Total Funding

104

Number of Employees

$16.1M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioAge Labs News

2022-04-13 - First Cohort Dosed in Phase 1b Trial of BioAge's BGE-105

(BUSINESS WIRE)– BioAge Labs, Inc., a biotechnology company developing therapeutics that target the molecular causes of aging to extend...

2022-04-13 - BioAge announces first cohort dosed in Phase 1b clinical trial ...

BioAge Labs, a biotech company developing therapeutics that target the molecular causes of muscle aging to extend healthy human lifespan,...

2022-04-06 - Known Medicine Appoints Kristen Fortney to Advisory Board

Dr. Fortney is the CEO and co-founder of BioAge Labs, a clinical stage drug discovery company in Richmond, CA. BioAge utilizes longitudinal...

2021-03-23 - SHIONOGI & CO., LTD. Shionogi : Notice regarding an initiation of Phase 2 clinical trial by BioAge aimed at treating older patients of COVID-19

Notice regarding an initiation of Phase 2 clinical trial by BioAge aimed at treating older patients of COVID-19 OSAKA, Japan, March, 23 and 23, 2021 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D. hereafter "Shionogi") today announced that BioAge Labs ...

2021-03-23 - Shionogi : Notice regarding an initiation of Phase 2 clinical trial by BioAge aimed at treating older patients of COVID-19

Notice regarding an initiation of Phase 2 clinical trial by BioAge aimed at treating older patients of COVID-19 OSAKA, Japan, March, 23 and 23, 2021 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D. hereafter "Shionogi") today announced that BioAge Labs ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$26M1045%N/A
#2
N/A1044%N/A
#3
$15.1M1045%N/A
#4
$28.1M1044%N/A
#5
$18.9M1055%N/A